All Stories

  1. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    Toby Maher

  2. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease

    Article • Expert Review of Clinical Immunology, September 2019, Taylor & Francis

    Toby Maher

  3. Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor

    Article • September 2019, European Respiratory Society (ERS)

    Toby Maher

  4. Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Toby Maher

  5. Recent advances in understanding idiopathic pulmonary fibrosis

    Article • F1000Research, May 2016, Faculty of 1000, Ltd.

    Toby Maher

  6. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?

    Article • Trends in Molecular Medicine, April 2016, Elsevier

    Toby Maher

  7. Current and Future Therapies for Idiopathic Pulmonary Fibrosis

    Article • Pulmonary Therapy, December 2015, Springer Science + Business Media

    Toby Maher

  8. Pirfenidone Post-Authorization Safety Registry (PASSPORT): Update and Concomitant Use of NAC and/or Corticosteroids

    Article • CHEST Journal, October 2015, Elsevier

    Toby Maher

  9. Response of the King's brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR)

    Article • September 2015, European Respiratory Society (ERS)

    Toby Maher

  10. A comparison of two scoring methods for the King's sarcoidosis questionnaire

    Article • September 2015, European Respiratory Society (ERS)

    Toby Maher

  11. Optimal use of gas transfer values in detecting pulmonary vascular involvement in sarcoidosis

    Article • September 2015, European Respiratory Society (ERS)

    Toby Maher

  12. Personalized medicine in idiopathic pulmonary fibrosis

    Article • Current Opinion in Pulmonary Medicine, September 2015, Wolters Kluwer Health

    Toby Maher

  13. New guideline on treatment of idiopathic pulmonary fibrosis

    Article • The Lancet Respiratory Medicine, September 2015, Elsevier

    Toby Maher, Francesco Bonella

  14. Rasch analysis and impact factor methods both yield valid and comparable measures of health status in interstitial lung disease

    Article • Journal of Clinical Epidemiology, September 2015, Elsevier

    Toby Maher, Harry Gosker

  15. Transcriptional phenotyping of fibrotic lung disease: a new gold standard?

    Article • The Lancet Respiratory Medicine, June 2015, Elsevier

    Toby Maher

  16. Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease

    Article • Respirology, March 2015, Wiley

    Toby Maher, Dr Marcos I. Restrepo

  17. Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis

    Article • European Respiratory Review, February 2015, European Respiratory Society (ERS)

    Toby Maher

  18. Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Toby Maher, Francesco Bonella

  19. Combination therapy: the future of management for idiopathic pulmonary fibrosis?

    Article • The Lancet Respiratory Medicine, November 2014, Elsevier

    Toby Maher

  20. UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey

    Article • Thorax, October 2014, BMJ

    Toby Maher

  21. Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?

    Article • Respirology, October 2014, Wiley

    Ms Anne-Marie Russell, Toby Maher

  22. Respiratory microbiome in IPF: cause, effect, or biomarker?

    Article • The Lancet Respiratory Medicine, July 2014, Elsevier

    Toby Maher

  23. Immunosuppression for Connective Tissue Disease–Related Pulmonary Disease

    Article • Seminars in Respiratory and Critical Care Medicine, March 2014, Thieme Publishing Group

    Toby Maher

  24. Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

    Article • Advances in Therapy, March 2014, Springer Science + Business Media

    Toby Maher

  25. The treatment of idiopathic pulmonary fibrosis

    Article • F1000Prime Reports, March 2014, Faculty of 1000, Ltd.

    Toby Maher

  26. Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology

    Article • Respirology, February 2014, Wiley

    Toby Maher

  27. Current and Emerging Treatment Options in Interstitial Lung Disease

    Article • January 2014, Springer Science + Business Media

    Toby Maher

  28. Idiopathic pulmonary fibrosis

    Article • December 2013, European Respiratory Society (ERS)

    Toby Maher

  29. Rituximab in severe, treatment-refractory interstitial lung disease

    Article • Respirology, November 2013, Wiley

    Toby Maher

  30. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine

    Article • Current Opinion in Pulmonary Medicine, September 2013, Wolters Kluwer Health

    Toby Maher

  31. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease

    Article • Respiratory Medicine, September 2013, Elsevier

    Toby Maher

  32. Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

    Article • Drug Design Development and Therapy, June 2013, Taylor & Francis

    Toby Maher, Phil Molyneaux

  33. Year in review 2012: Acute lung injury, interstitial lung diseases, sleep and physiology

    Article • Respirology, March 2013, Wiley

    Toby Maher

  34. Exercise-induced haemoptysis: a thoroughbred cause?

    Article • Thorax, February 2013, BMJ

    Toby Maher

  35. Successful treatment of progressive diffuse PEComatosis

    Article • European Respiratory Journal, November 2012, European Respiratory Society (ERS)

    Toby Maher

  36. The Diagnosing and Staging of Idiopathic Pulmonary Fibrosis

    Article • Clinical Pulmonary Medicine, November 2012, Wolters Kluwer Health

    Toby Maher

  37. A Clinical Approach to Diffuse Parenchymal Lung Disease

    Article • Immunology and Allergy Clinics of North America, November 2012, Elsevier

    Toby Maher

  38. Current and novel drug therapies for idiopathic pulmonary fibrosis

    Article • Drug Design Development and Therapy, September 2012, Taylor & Francis

    Toby Maher

  39. Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: Incidence, all-cause mortality and characteristics at diagnosis

    Article • Respirology, June 2012, Wiley

    Toby Maher

  40. Diffuse parenchymal lung disease

    Article • Medicine, June 2012, Elsevier

    Toby Maher

  41. A Mucin 5B (MUC5B) Promoter Polymorphism In Sarcoidosis

    Article • May 2012, American Thoracic Society

    Toby Maher

  42. The Respiratory Microbiome In Idiopathic Pulmonary Fibrosis

    Article • May 2012, American Thoracic Society

    Toby Maher

  43. Pulmonary Sarcoidosis: Integration Of The Composite Physiologocal Index And HRCT Patterns For Clinical Staging

    Article • May 2012, American Thoracic Society

    Toby Maher

  44. Year in review 2011: Acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer

    Article • Respirology, March 2012, Wiley

    Toby Maher

  45. Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to Treatment

    Article • Clinics in Chest Medicine, March 2012, Elsevier

    Toby Maher

  46. Pulmonary fibrosis

    Article • February 2012, Taylor & Francis

    Toby Maher

  47. Incidence of the Pneumoconioses in the United Kingdom General Population between 1997 and 2008

    Article • Respiration, January 2012, Karger Publishers

    Toby Maher

  48. Rituximab Therapy In Severe Interstitial Lung Disease

    Article • May 2011, American Thoracic Society

    Toby Maher

  49. Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis?

    Article • Respirology, March 2011, Wiley

    Toby Maher

  50. Year in review 2010: Interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer

    Article • Respirology, March 2011, Wiley

    Toby Maher

  51. Vibration Response Imaging Correlates With Air Flow Measured By Spirometry

    Article • May 2010, American Thoracic Society

    Toby Maher

  52. Year in review 2009: Interstitial lung diseases, acute injury, sleep, physiology, imaging and bronchoscopic intervention

    Article • Respirology, January 2010, Wiley

    Toby Maher

  53. Lysophosphatidic Acid Induces αvβ6 Integrin-Mediated TGF-β Activation via the LPA2 Receptor and the Small G Protein Gαq

    Article • American Journal Of Pathology, April 2009, Elsevier

    Toby Maher

  54. Understanding Nonspecific Interstitial Pneumonia: The Need for a Diagnostic Gold Standard

    Article • American Journal of Respiratory and Critical Care Medicine, February 2009, American Thoracic Society

    Toby Maher

  55. The diagnosis of idiopathic pulmonary fibrosis and its complications

    Article • Expert Opinion on Medical Diagnostics, November 2008, Informa Healthcare

    Toby Maher

  56. Vibration Response Imaging Technology in Healthy Subjects

    Article • American Journal of Roentgenology, September 2008, American Roentgen Ray Society

    Toby Maher

  57. Native Valve Aspergillus Endocarditis Complicating Lung Transplantation

    Article • The Journal of Heart and Lung Transplantation, August 2008, Elsevier

    Toby Maher

  58. Diffuse parenchymal lung disease

    Article • Medicine, May 2008, Elsevier

    Toby Maher

  59. CT Findings of Varicella Pneumonia After Lung Transplantation

    Article • American Journal of Roentgenology, June 2007, American Roentgen Ray Society

    Toby Maher

  60. Acute breathlessness

    Article • British Journal of Hospital Medicine, March 2007, Mark Allen Group

    Toby Maher

  61. REPRODUCIBILITY OF RELATIVE REGIONAL ASSESSMENT USING THE VIBRATION RESPONSE IMAGING DEVICE

    Article • CHEST Journal, October 2006, Elsevier

    Toby Maher

  62. Perspectives for the future

    Article • European Respiratory Society (ERS)

    Toby Maher